Latest filing published 18 Sept 2026 for Revolution Medicines, Inc., €13k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Margaret A. Horn discloses dealings in 2 companies, chiefly Revolution Medicines, Inc. and Sangamo Therapeutics, Inc. In total, 42 filings cover trades dated from 17 June 2021 to 16 September 2026.
Sales make up the whole of the open-market record (23 sales, €3.8M). Besides market trades, the filings include 9 share grants and 10 option exercises. 2026 to date brings no purchases and 3 sales.
The record was last updated on 18 September 2026 with an open-market sale (€845k) in Revolution Medicines, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations